Quality indicators, or quality measures, are used to objectively assess the quality of care by determining whether certain evidenced-based, expert-recommended, or patient-centric aspects of care are being followed. These programs have also developed standardized care pathways to provide evidenced-based algorithms to improve focused aspects of clinical care. Other initiatives are focusing on the development of learning health systems including ImproveCareNow and IBD Qorus these are virtual platforms and networked practices which allow for sharing of data and best practices, along with QI training for IBD centers and practices, predominantly in the United States. Some initiatives are aimed at defining quality of care in IBD, such as the American Gastroenterology Association (AGA) IBD performance measures, 8 the Crohn's & Colitis Foundation (CCFA) process and outcome measures, 9 and the International Consortium for Health Outcomes Measurement (ICHOM) IBD standard set. 7 Several QI initiatives have been developed to address these issues, although in different ways. 1 IBD care is expensive and complex-patients commonly require multidisciplinary care, biologic medications, inpatient care, and surgeries. 1 There are many aspects of IBD care that make it apt for quality improvement (QI), including the significant variation in how care is delivered, 2, 3, 4 the prevalence of potentially preventable disease- and medication-associated complications 5, 6 and a significant direct and indirect individual and societal cost burden of illness. Inflammatory bowel diseases (IBD), including CD and UC are chronic, debilitating, and expensive conditions. Keywords: Quality indicator, health care Inflammatory bowel disease Crohn disease Colitis, ulcerative Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |